Search for Clinical Trial Results

Sponsored By

Primary Fanconi Syndrome - 25 Studies Found

Status Study
Completed Study Name: Evaluation of Fanconi Syndrome and Cystinosis
Condition:
  • Cystinosis
  • Fanconi Syndrome

Date: 1999-10-18
Completed Study Name: Fanconi Syndrome Due to ARVs in HIV-Infected Persons
Condition:
  • HIV Infections
  • Fanconi Syndrome
  • Cystinosis
  • Nephropathic Cystinosis
  • Renal
  • Beta-thalassemia
  • Myelodysplastic Syndromes
  • Cystinosis
  • Nephropathic Cystinosis

Date: 2011-09-09
Interventions: Drug: Cysteamine bitartrate 500 mg total, single dose taken orally on visits 2, 3 & 4 which must occ
Completed Study Name: Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Date: 2009-10-22
Interventions:
  • Drug: Cystagon® (Cysteamine Bitartrate)

Completed Study Name: Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Date: 2009-03-27
Interventions:
  • Drug: Cystagon®

Recruiting Study Name: Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A
Condition: Fanconi Anemia
Date: 2017-04-26
Interventions:
  • Procedure: IV administration of Genetically Engineered Hematopoietic Stem/Pr
Recruiting Study Name: Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1
Condition: Fanconi Anemia
Date: 2016-09-06
Interventions:
  • Drug: filgrastim G-CSF (12

Recruiting Study Name: Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor
Condition: Fanconi Anemia
Date: 2016-02-05
Interventions:
  • Drug: G-CSF D1 to D4 : Injecti
Next >>>